Fate Therapeutics Inc (NASDAQ:FATE)
| 21.24 BATS BZX Real-Time Price As of 9:52am ET |  -0.60 / -2.75%Today’s Change | 20.49 Today|||52-Week Range 97.43 | -63.70% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Tahl Cindy R Secretary & General Counsel |  Sale | 7/01/2021 | 50,000 | $84.56 | $4.2M | -76.85% |
Wolchko J Scott President & Chief Executive Officer | Sale | 7/23/2021 | 30,000 | $85.28 | $2.6M | -74.67% |
Wolchko J Scott President & Chief Executive Officer | Sale | 7/22/2021 | 21,773 | $86.19 | $1.9M | -74.60% |
Wolchko J Scott President & Chief Executive Officer | Sale | 10/22/2021 | 30,000 | $58.88 | $1.8M | -63.00% |
Wolchko J Scott President & Chief Executive Officer | Sale | 8/19/2021 | 20,000 | $88.01 | $1.8M | -74.51% |
Tahl Cindy R Secretary & General Counsel | Sale | 1/03/2022 | 27,812 | $59.86 | $1.7M | -63.79% |
Wolchko J Scott President & Chief Executive Officer | Sale | 5/20/2021 | 20,000 | $77.16 | $1.5M | -71.74% |
Valamehr Bahram Chief Development Officer | Sale | 6/14/2021 | 16,380 | $89.11 | $1.5M | -75.74% |
Tahl Cindy R Secretary & General Counsel | Sale | 10/01/2021 | 21,844 | $58.96 | $1.3M | -63.31% |
Dulac Edward John Iii Chief Financial Officer | Sale | 9/28/2021 | 19,460 | $62.53 | $1.2M | -64.09% |
Page of 14